Skip to content
TradingPilot
Performance
Theme
Sign in

News & calendar

news: as of 2026-10-12
What the marks mean

Importance is a model-assigned 1–5 on published stories, not a market forecast.

Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.

An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.

Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.

Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.

A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.

Ahead

scheduled · today and tomorrow · calendar refreshed 2026-10-12

Mon · 12 Oct · today

Tue · 13 Oct

Behind

published · newest first

Sun · 9 Aug

macro

11:35
Yahoo Finance

Wall Street weighs surprise July jobs contraction as stocks rally on fading rate-hike odds

The July employment report showed the economy lost 23,000 jobs with unemployment at 4.1%, and Wall Street economists called the details weak — 'very little to like', per Ameriprise's chief economist — even as equities rallied on bets the print takes a Fed rate hike off the table.

Article preview

'Very little to like': Wall Street assesses surprise July jobs report as stocks jump Ines Ferré · Senior Business Reporter Sun, August 9, 2026 at 9:35 PM GMT+10 2 min read ^GSPC ^IXIC ^DJI NVDA MSFT Wall Street is increasingly betting the latest jobs report will take a Fed rate hike off the table and give stocks room to climb. The Bureau of Labor Statistics' July labor market report showed the economy lost 23,000 jobs, far short of expectations. The unemployment rate fell to 4.1% as labor force participation dropped to a near-pandemic low. More from Yahoo Scout What are analysts' stock market…

Markets open original ↗

Fri · 7 Aug

regulation

12:22
Yahoo Finance

Solar Stocks Rise After Trump Imposes 15% Tariff, Minimum Prices on Polysilicon Imports

The White House imposed a 15% Section 232 tariff and minimum price floors on polysilicon imports effective December 4, 2026 ($21/kg polysilicon, $100/kg ingots and wafers, $0.22/watt cells, $0.38/watt modules), targeting Chinese competition and authorizing a Commerce Department incentive program for domestic polysilicon production investment; First Solar (+4.7%), Enphase (+2.3%) and SolarEdge (+1.7%) shares jumped premarket on the news.

Markets open original ↗

Thu · 6 Aug

Wed · 5 Aug

Tue · 4 Aug

regulation

05:00
GlobeNewswire

Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks

The European Commission approved an extension of the indication for MenQuadfi (Meningococcal Group A, C, W and Y conjugate vaccine) to include infants from six weeks of age, broadening the vaccine's addressable population in the EU.

Markets open original ↗

Mon · 3 Aug

earnings

20:15
GlobeNewswire

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

CRISPR Therapeutics reported that CASGEVY generated second quarter 2026 revenue of $76 million, representing 78% growth quarter-over-quarter and 151% growth year-over-year.

Markets open original ↗

partnership

12:00
GlobeNewswire

Taysha Gene Therapies and Catalent Expand Strategic Partnership for Commercial Manufacturing of TSHA-102

Catalent will serve as Taysha's primary commercial manufacturer following potential U.S. FDA approval of TSHA-102, providing GMP manufacturing and commercial supply at its FDA-licensed commercial gene therapy facility in Harmans, Maryland.

Markets open original ↗

The wire

everything that arrived · 7 days